Literature DB >> 22119593

Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004-2009. Is rubella susceptibility increasing?

Lisa Byrne1, Lisa Brant, Claire Reynolds, Mary Ramsay.   

Abstract

Antenatal testing for rubella susceptibility is undertaken to identify women at risk of exposure during pregnancy and to target post-partum immunisation. To evaluate the current rubella control programme and to inform future planning, data on anti-rubella IgG levels in antenatal sera tested by NHS Blood and Transplant were reviewed. The frequency of women with anti-rubella IgG <10 IU/mL increased by 60% over the 6-year study period and rates were significantly higher among younger women. The screening cut-off level of 10 IU/mL, used to identify women at risk, was determined in 1995 on the basis of early epidemiological studies and the correlates for protection now need review to support the appropriate management of a young immunised antenatal population. Ethnic minorities continue to be at increased risk of rubella susceptibility reinforcing the need to identify and opportunistically immunise these women. Crown
Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119593     DOI: 10.1016/j.vaccine.2011.11.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Results of continuous monitoring of the performance of rubella virus IgG and hepatitis B virus surface antibody assays using trueness controls in a multicenter trial.

Authors:  Tamara Kruk; Sam Ratnam; Jutta Preiksaitis; Allan Lau; Todd Hatchette; Greg Horsman; Paul Van Caeseele; Brian Timmons; Graham Tipples
Journal:  Clin Vaccine Immunol       Date:  2012-08-15

2.  Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Authors:  P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-10       Impact factor: 3.267

3.  Response to third rubella vaccine dose.

Authors:  Lotta Siira; Hanne Nøkleby; Regine Barlinn; Øystein R Riise; Ingeborg S Aaberge; Susanne G Dudman
Journal:  Hum Vaccin Immunother       Date:  2018-06-21       Impact factor: 3.452

4.  Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome.

Authors:  Hanqing He; Rui Yan; Xuewen Tang; Yang Zhou; Xuan Deng; Shuyun Xie
Journal:  BMC Infect Dis       Date:  2016-11-30       Impact factor: 3.090

5.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

6.  Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.

Authors:  Zemenu Yohannes Kassa; Siraj Hussen; Solomon Asnake
Journal:  Hum Vaccin Immunother       Date:  2020-03-20       Impact factor: 3.452

7.  Durability of humoral immune responses to rubella following MMR vaccination.

Authors:  Stephen N Crooke; Marguerite M Riggenbach; Inna G Ovsyannikova; Nathaniel D Warner; Min-Hsin Chen; Lijuan Hao; Joseph P Icenogle; Gregory A Poland; Richard B Kennedy
Journal:  Vaccine       Date:  2020-11-12       Impact factor: 3.641

Review 8.  Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Authors:  Shintaro Sagami; Taku Kobayashi; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2018-07-17

9.  How useful is a history of rubella vaccination for determination of disease susceptibility? A cross-sectional study at a public funded health clinic in Malaysia.

Authors:  Ai Theng Cheong; Seng Fah Tong; Ee Ming Khoo
Journal:  BMC Fam Pract       Date:  2013-01-31       Impact factor: 2.497

10.  Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign.

Authors:  Behnam Honarvar; Mohsen Moghadami; Afagh Moattari; Amir Emami; Neda Odoomi; Kamran Bagheri Lankarani
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.